Replimune Group, Inc. — Director's Dealing 2020

Dec 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-11

Reporting Person: Esposito Pamela (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-11	Common Stock	M	12590	$3.3	Acquired	125290	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Employee Stock Option (right to buy)	$3.3	M	12590	Disposed	2027-07-26	Common Stock (12590)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vested on July 26, 2018 and the remainder of the shares underlying this stock option vested or will vest, as applicable, in equal monthly installments thereafter until July 26, 2021.